Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.
Press releases published on April 30, 2025
ZA Miner Launches Free Cloud Mining Platform for Bitcoin and Dogecoin
GlobeNewswire
·
April 30, 2025
Image by ZA FUNDINGS LTD MIDDLESEX, United Kingdom, April 30, 2025 (GLOBE NEWSWIRE) -- ZA Miner, a cloud mining company based in the United Kingdom, has announced the introduction of a free Bitcoin cloud mining service, allowing users to mine Bitcoin (BTC) …
ZAMiner Bitcoin Insights on How to Easily Earn Passive Income Every Day
GlobeNewswire
·
April 30, 2025
Image by ZAMiner MIDDLESEX, United Kingdom, April 30, 2025 (GLOBE NEWSWIRE) -- ZA Miner, a UK-based cloud mining platform operated by ZA FUNDINGS LTD, has shared valuable insights into earning passive income through cryptocurrency activities, particularly …
BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire
·
April 30, 2025
RESEARCH TRIANGLE PARK, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Citizens Life Sciences Conference in New York on Thursday, May 8, …
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 30, 2025
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update Continuing to advance clinical active immunotherapy portfolio for precision prevention of neurodegenerative diseases Positive immunogenicity and good safety in interim …
NodThera’s Oral NLRP3 Inhibitor NT-0796 Enhances and Sustains Weight Loss in Combination with GLP-1
GlobeNewswire
·
April 30, 2025
Data published in Obesity journal show enhanced weight loss effect of NT-0796 when combined with semaglutide in preclinical obesity model Obese state completely reversed with 30% weight loss and reversal of hypothalamic inflammation NT-0796 sustained …
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
GlobeNewswire
·
April 30, 2025
Sanofi and CD…
ECARX Announces First Quarter 2025 Unaudited Financial Results
GlobeNewswire
·
April 30, 2025
SHANGHAI, April 30, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the quarter ended March 31, 2025. “The strong momentum we built …
Communiqué de presse : Sanofi et CD&R finalisent la cession d’Opella et créent un leader mondial de la santé grand public
GlobeNewswire
·
April 30, 2025
Sanofi et CD…
Fitch updates Marex’s outlook to positive due to strong earnings and diversification of franchise
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Fitch Ratings (Fitch) yesterday announced that it has revised the outlook of Marex Group plc’s Long-Term Issuer Default Rating (IDR) to positive from stable, and has affirmed its Long-Term IDR at ‘BBB-’. The …
Emerita Files NI 43-101 Technical Report for the IBW Project, Marking a 35% Increase in Total Indicated Resources and a 44% Increase in Total Inferred Resources
GlobeNewswire
·
April 30, 2025
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX – V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) reports that it has filed the independent NI 43-101 compliant technical report for its Iberian Belt West Project (“IBW” …
XORTX Provides Update on FDA Type B Meeting Request
GlobeNewswire
·
April 30, 2025
● XORTX will focus on key steps to advance a NDA filing for Gout indication ● CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical …
Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 8:30 …
OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
GlobeNewswire
·
April 30, 2025
Urcosimod phase 2 trial treating Neuropathic Corneal Pain (“NCP”) patients was initiated in October 2024 and designed as a double-masked, randomized, 12-week placebo-controlled trial. OKYO Pharma plans to analyze the efficacy data from the 17 patients who …
CLIQ: Einladung zum Earnings Call für das erste Quartal 2025
GlobeNewswire
·
April 30, 2025
DÜSSELDORF, 30. April 2025 – Der CLIQ-Konzern wird am Donnerstag, den 8. Mai 2025, seine Finanzergebnisse und Highlights für das erste Quartal 2025 präsentieren. Der Finanzbericht Q1 2025 und die begleitende Präsentation zum Earnings Call werden ab 7:30 …
CLIQ: Invitation to First Quarter 2025 Results Presentation
GlobeNewswire
·
April 30, 2025
DÜSSELDORF, 30 April 2025 – The CLIQ Group will report and present its first quarter 2025 financial results and highlights on Thursday, 8 May 2025. The 1Q 2025 Financial Report and a slides deck to accompany the earnings call will be available at https:// …
Oatly Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
MALMÖ, Sweden, April 30, 2025 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY) (“Oatly”, the “Company” or the “Group”), the world’s original and largest oat drink company, today announced financial results for the first quarter ended March 31, 2025. Jean- …
Parents say stress management most important skill kids aren’t learning
GlobeNewswire
·
April 30, 2025
FindTutors, in partnership with GoStudent reveals that kids are struggling to cope with exam stress now more than ever This comes as referrals for anxiety in children in the UK have more than doubled since before the pandemic As Stress Awareness Month …
PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate
GlobeNewswire
·
April 30, 2025
New high-quality cell growth supplement for cell manufacturing applications including in regenerative medicine and cell therapies Human Platelet Lysate (HPL) offers a safer and sustainable alternative to Fetal Bovine/ Calf Serum (FBS/FCS) Gamma-irradiated …
Axi Celebrates Axi Select’s Two $1M Funded Traders in Sydney, Australia
GlobeNewswire
·
April 30, 2025
SYDNEY, April 30, 2025 (GLOBE NEWSWIRE) -- Leading online FX and CFD broker Axi proudly announced a few months ago their first-ever Axi Select traders to have reached the Pro M stage of their capital allocation program, with each securing $1 million in …
CIRRO E-Commerce enters Polish market and joins E-Commerce Connect Poland as a platinum sponsor
GlobeNewswire
·
April 30, 2025
WARSAW, Poland, April 30, 2025 (GLOBE NEWSWIRE) -- CIRRO E-Commerce, a leading global e-commerce logistics solution provider, announces its official entry into the Polish market. To mark this strategic expansion, the company will participate as a Platinum …